HEART FAILURE IN PREGNANCY

HEART FAILURE IN PREGNANCY Afshan Hameed, MD, FACOG, FACC Assistant Professor, Maternal Fetal Medicine & Cardiology University of California, Irvine M...
Author: Adam Chandler
0 downloads 0 Views 775KB Size
HEART FAILURE IN PREGNANCY Afshan Hameed, MD, FACOG, FACC Assistant Professor, Maternal Fetal Medicine & Cardiology University of California, Irvine March of Dimes 3-7-11

3 million women age 18-44 in the US have heart disease ~ 1% of pregnant women

1

Pregnancy Related Deaths North Carolina 1996-99 Cause of Death Cardiomyopathy

% of All Deaths 21%

Hemorrhage

14

PIH

10

CVA

9

Chronic condition

9

AFE

7

Infection

7

Pulmonary embolism

6

Berg CJ et al. Obstet Gynecol 2005

Important cause of maternal morbidity and mortality

oWhat causes it?  The basics of cardiac physiology  Underlying cardiac disease

Pregnancy induced cardiac failure oCan we prevent?

2

Structural Cardiac Disease

Pregnancy induced cardiac dysfunction

Heart Failure in Pregnancy Arrhythmias

Other

oWhat causes it?  The basics of cardiac physiology  Underlying cardiac disease

 Pregnancy induced cardiac failure oCan we prevent?

3

Hemodynamic changes oPlasma volume oHeart rate oStroke volume oCardiac output

Hemodynamic Changes During Pregnancy

Plasma Volume

Pitkin RM Clin Obstet Gyn 1976;19:489

Hemodynamic Changes During Pregnancy

Cardiac Output

Robson et al Am J Physiol 1989;256:H1060

4

……..PHYSIOLOGIC CHANGES

o AUSCULTATION  96% have a “functional murmur”

• Mid-systolic and low intensity - LUSB  Third heart sound is common

o EKG CHANGES  QRS axis deviation  ST-T wave changes  Sinus tachycardia and arrhythmias

Chest X-ray During Normal Pregnancy

Cardiac Chamber Dimensions (mm) During Normal Pregnancy and Puerperium

RA 19%. RV 18%. LA 12%. LV 6%

5

PHYSIOLOGIC CHANGES “Pregnancy Mimics Heart Disease” o SYMPTOMS  Reduction of exercise tolerance  Hyperventilation - shortness of breath

o SIGNS  Edema  JVD  Murmurs

oWhat causes it?  The basics of cardiac physiology

Underlying cardiac disease  Pregnancy induced cardiac failure oCan we prevent?

Valvular Heart Disease in Pregnancy

-Caseo24 yo Hispanic female G1 @ 33 wks oProgressive dyspnea for 3 months oSOB and productive cough oCXR: Bilateral infiltrates oEKG: Sinus tachycardia oTreated for pneumonia x 5 days oNo improvement

6

SYMPTOMS OF MITRAL STENOSIS DYSPNEA - Increased left atrial pressure FATIGUE - Fixed cardiac output ANKLE EDEMA - Right heart failure

Cardiac Risk in Rheumatic Mitral Stenosis

Silversides et al AJC 2003;91:1382

7

Aortic Stenosis oRare in pregnancy oPregnancy contraindicated if symptomatic

SYMPTOMS OF AORTIC STENOSIS Chest pain Dizziness/ Syncope Dyspnea

Aortic Stenosis in Pregnancy

-Caseo 36 yo Hispanic female G2 P1 at 16 3/7 wks o NYHA functional class II o EKG: Normal sinus rhythm o Echocardiogram:

 EF 66%,  Bicuspid aortic valve, AVA 0.9 cm2 , Peak gradient 64 mm Hg

8

Valvular Disease in Pregnancy

-Case-

o Symptoms of CHF at ~ 27 weeks

o Percutaneous Aortic balloon valvuloplasty @ 28 weeks – AVA 1.2 – Peak gradient 40 mm Hg

o Delivery at 36 weeks after fetal lung maturity

Aortic Stenosis and Pregnancy

Maternal Outcome 100%

100%

Mild Moderate

50%

Severe

43%

All

33% 25% 8% 0%

0%

0%

CHF

0% Arrhythmias

Hameed et al JACC 2001;37:893-899

oWhat causes it?  The basics of cardiac physiology  Underlying cardiac disease

Pregnancy induced cardiac failure oCan we prevent?

9

Cardiomyopathy

Case # 1 o 34 year old AA gravida 1 @ 20 weeks o Pregnancy complicated by hypercalcemia, pancreatitis, parathyroidectomy o Uncomplicated course thereafter o Normal delivery at 40 weeks, male infant 3450 gm with Apgars of 9 and 9

……….. Case #1 o Presented with shortness of breath and cough 7 days after delivery o CXR: bilateral alveolar infiltrates o Echo:  Global hypokinesis with EF 35%  No wall motion or valvular abnormality

o Treatment: Loop diuretics, ACE inhibitors, beta blockers, digoxin

……….. Case #1

oFollow up at 3 months

oNYHA functional class I oEcho:  Normal left ventricular function  EF 55%

10

Peripartum Cardiomyopathy (PPCM)

What is PPCM? An idiopathic dilated CMP presenting in the 2nd or 3rd trimester of pregnancy or within several months postpartum associated with depressed LV systolic function

What is PPCM? o Development of HF in the last month of pregnancy or within 5 months of delivery o Absence of identifiable cause for HF o Absence of recognizable heart disease prior to the last month of pregnancy o Left ventricular systolic dysfunction demonstrated by echocardiography NIH Workshop Recommendations and Review 1997, Pearson et al, JAMA 2000; 283:1183

11

PPCM – Time of Diagnosis Elkayam et al. Circulation 2005;111:2050 75

Number of patients

Early Traditional 50

N=123 25

0

< 27

28-32

33-36

37-40

1

2

Weeks

3

4

5

Months PP DELIVERY

Incidence Incidence of peripartum cardiomyopathy in various populations STUDY

STUDY POPULATION LOCATION

INCIDENCE OF PERIPARTUM CARDIOMYOPATHY

Davidson and Parry [] Meadows [] Woolford [] Cunningham et al. []

Nigeria (Hausa tribe) United States United States United States

1/100 deliveries 1/1300 live births 1/4000 live births 1/15,150 deliveries

 Recent surveys in the US and Canada found a ratio of 1~ 2300 live births (~1300 cases/year)  Higher incidence reported in South Africa (1:1000) and in Haiti (1:300 ) Circ 2004;110:III 520

Peripartum Cardiomyopathy

Risk Factors o The exact cause of PPCM remains unknown        

Age >30 Poor nutrition - ?Selenium deficiency African American Multiple gestation Long term tocolytic therapy History of preeclampsia Immunological mechanisms / Myocarditis Stress-activated proinflammatory cytokines (TNF- or interleukin 1)  Abnormalities of relaxin, prolactin

12

Who is at Risk?

PREGNANCY ASSOCIATED CARDIOMYOPATHY

Index Pregnancy 50% 42% 40%

n=123 30%

20%

17%

17% 14% 10%

10%

0% 1st

2nd

3rd

4th



5th

Elkayam et al. Circulation 2005;111:2050

PPCMP

How Does it Present? oHeart failure oArrhythmias +/- HF oThromboembolism oAsymptomatic LV dysfunction

13

Outcome of PPCM 123 Patients Recovery EF > 50%

Persistent LV dysfxn

(at last f/u)

(at last f/u)

54%

41%

Cardiac Transplantation

4% Death

9% (2 pts died post transplant)

Elkayam et al. Circulation 2005;111:2050

Predictors of LV dysfunction? o Severe of LV dilatation and systolic dysfunction @ diagnosis

o Evidence for myocardial cell damage (Troponin T level >0.04 ng/ml within 2 weeks of diagnosis) (Hu CL et al Heart 2007;93:488-90)

o Lack of recovery at 2-6 months (Elkayam et al. Circulation 2005;111:2050 & Amos et al AHJ 2006 ;152:509)

o African American race

When Does the LV Recover?

14

Recovery of LVEF in 40 Patients 60 48 ± 11%

*

50 45 ± 13%

46 ± 14%

LVEF %

40 30 30 ± 11% 20

*p